You’ve just seen your favorite rock band in a packed arena — and as the excitement fades, the worry sets in. Was this a “super spreader” event? When was your last booster? In that moment, wouldn’t it be a relief to know you could just take a pill to protect yourself? A recent study presented…
Google: AI is more profound than fire and a key to the future of life science R&D
Google CEO Sundar Pichai has often highlighted the transformative impact of AI, stating that it’s a “more profound” tool than the human discoveries of fire or electricity. Shweta Maniar, Global Director of Healthcare and Life Sciences at Google, echoed this sentiment in a recent interview. AI’s applications in the life sciences are broad, and the…
This week in R&D: AMD puts R&D centers in Taiwan cities, Northvolt relocates battery operations to its Sweden R&D center
The R&D World Index (RDWI) for the week ending August 23, 2024, closed at 3,947.43 for the 25 companies in the RDWI. The Index was up 1.78% (or 68.94 basis points). Twenty-two RDWI members gained value last week from 0.11% (Meta Platforms) to 7.23% (Ford Motor). Three RDWI members lost value the previous week from…
Certara’s AI answer to medical writing challenges in pharma
For decades, the pharmaceutical industry, along with other highly regulated sectors, has grappled with the often-cumbersome process of medical writing. Writers must comply with strict guidelines from regulatory bodies such as the FDA and EMA when creating clinical trial reports and regulatory submissions. Failure to comply can result in delays or rejection. The advent of…